Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Oct-24 5:46 PM View:  | Camp4 Therapeutics Corp (CAMP) | 15-Oct-24 | Conversion | 8,917 | -- | -- | 6% 145.94K to 154.86K | |
| 18-Sep-24 5:00 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 16-Sep-24 | Option Exercise | 2,667 | -- | -- | 33% 8.0K to 10.67K | |
| 07-Jun-24 4:30 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 05-Jun-24 | Grant | 4,000 | -- | -- | 10% 38.84K to 42.84K | |
| 19-Sep-23 4:48 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 16-Sep-23 | Option Exercise | 2,666 | -- | -- | 7% 36.17K to 38.84K | |
| 05-Jun-23 4:15 PM View: | Omega Therapeutics, Inc. (OMGA) | 02-Jun-23 | Sale (Planned) | 5,000 | $8.00 | $40,000.00 | (< 1%) 744.12K to 739.12K | |
| 02-Jun-23 4:27 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 01-Jun-23 | Grant | 4,000 | -- | -- | 12% 32.17K to 36.17K | |
| 03-May-23 4:05 PM View: | Omega Therapeutics, Inc. (OMGA) | 01-May-23 | Sale (Planned) | 5,000 | $8.00 | $40,000.00 | (< 1%) 749.12K to 744.12K | |
| 10-Apr-23 4:05 PM View: | Omega Therapeutics, Inc. (OMGA) | 06-Apr-23 | Sale (Planned) | 5,000 | $8.00 | $40,000.00 | (< 1%) 754.12K to 749.12K | |
| 20-Mar-23 4:05 PM View: | Omega Therapeutics, Inc. (OMGA) | 17-Mar-23 | Sale (Planned) | 10,000 | $8.00 | $80,000.00 | (1%) 764.12K to 754.12K | |
| 11-Jan-23 4:14 PM View: | Omega Therapeutics, Inc. (OMGA) | 10-Jan-23 | Sale (Planned) | 20,000 | $8.00 | $160,000.00 | (3%) 784.12K to 764.12K | |
| 15-Sep-22 4:10 PM View: | Omega Therapeutics, Inc. (OMGA) | 14-Sep-22 | Sale (Planned) | 10,000 | $8.00 | $80,000.00 | (1%) 794.12K to 784.12K | |
| 18-Feb-21 5:34 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 16-Feb-21 | Market Sale (Planned) | 3,750 | $12.05 | $45,187.50 | (1%) 325.46K to 321.71K | 5% |
| 10-Feb-21 5:29 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 08-Feb-21 | Market Sale (Planned) | 3,750 | $13.04 | $48,900.00 | (1%) 329.21K to 325.46K | 10% |
| 18-Nov-20 4:33 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 17-Nov-20 | Market Sale (Planned) | 5,357 | $8.75 | $46,873.80 | (2%) 344.57K to 339.21K | (34%) |
| 18-Nov-20 4:33 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 16-Nov-20 | Market Sale (Planned) | 633 | $8.98 | $5,684.34 | (< 1%) 345.2K to 344.57K | (30%) |
| 19-Oct-20 6:36 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 19-Oct-20 | Market Sale (Planned) | 5,673 | $8.75 | $49,638.80 | (2%) 340.87K to 335.2K | (34%) |
| 16-Oct-20 4:39 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 15-Oct-20 | Market Sale (Planned) | 317 | $8.75 | $2,773.75 | (< 1%) 341.19K to 340.87K | (34%) |
| 16-Sep-20 8:32 AM View: | Syros Pharmaceuticals, Inc. (SYRS) | 15-Sep-20 | Market Sale (Planned) | 5,990 | $10.39 | $62,236.10 | (2%) 347.18K to 341.19K | (13%) |
| 19-Aug-20 4:33 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 17-Aug-20 | Market Sale (Planned) | 5,990 | $12.59 | $75,414.10 | (2%) 353.17K to 347.18K | 7% |
| 17-Jul-20 4:11 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 15-Jul-20 | Market Sale (Planned) | 5,990 | $11.85 | $70,981.50 | (2%) 359.16K to 353.17K | 1% |
| 16-Jun-20 4:53 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 15-Jun-20 | Market Sale (Planned) | 5,990 | $8.75 | $52,412.50 | (2%) 365.15K to 359.16K | (34%) |
| 15-May-20 5:13 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 15-May-20 | Market Sale (Planned) | 5,990 | $9.22 | $55,242.20 | (2%) 371.14K to 365.15K | (27%) |
| 17-Apr-20 4:02 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 15-Apr-20 | Market Sale (Planned) | 23,960 | $8.75 | $209,650.00 | (6%) 395.1K to 371.14K | (34%) |
| 19-Aug-19 4:08 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 16-Aug-19 | Market Sale (Planned) | 22,700 | $10.00 | $227,000.00 | (5%) 417.8K to 395.1K | (17%) |
| 19-Aug-19 4:08 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 15-Aug-19 | Market Sale (Planned) | 2,300 | $10.00 | $23,000.00 | (< 1%) 420.1K to 417.8K | (17%) |
| 16-Aug-17 4:08 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 14-Aug-17 | Market Sale (Planned) | 3,282 | $22.00 | $72,204.00 | (< 1%) 423.38K to 420.1K | 47% |
| 27-Jul-17 4:09 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 25-Jul-17 | Market Sale (Planned) | 3,282 | $22.09 | $72,495.80 | (< 1%) 426.67K to 423.38K | 47% |
| 13-Feb-17 10:00 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 09-Feb-17 | Disposition (other) | 106,667 | -- | -- | (20%) 533.33K to 426.67K | |
| 03-Jul-12 4:15 PM View: | Enzon Pharmaceuticals Inc. (ENZN) | 02-Jul-12 | Grant | 10,669 | -- | -- | 55% 19.56K to 30.23K | |
| 16-Mar-12 3:29 PM View: | Enzon Pharmaceuticals Inc. (ENZN) | 15-Mar-12 | Market Sale | 2,000 | $6.92 | $13,842.20 | (9%) 21.56K to 19.56K | 21160% |
| 06-Jul-11 12:37 PM View: | Enzon Pharmaceuticals Inc. (ENZN) | 01-Jul-11 | Grant | 7,382 | -- | -- | 52% 14.18K to 21.56K | |
| 06-Jul-10 7:01 PM View: | Enzon Pharmaceuticals Inc. (ENZN) | 01-Jul-10 | Grant | 7,043 | -- | -- | 99% 7.14K to 14.18K | |
| 27-Apr-10 8:35 PM View: | Enzon Pharmaceuticals Inc. (ENZN) | 19-Apr-10 | Grant | 7,137 | -- | -- | 100% 0 to 7.14K |